[1]Li PK, Chow KM, Van de Luijtgaarden MW, et al.Changes in the worldwide epidemiology of peritoneal dialysis[J].Nat Rev Nephrol, 2017, 13(2):90-103
[2]Martin, Wilkie, Simon, et al.Insights on Peritoneal Dialysis in China[J].Peritoneal dialysis international：journal of the International Society for Peritoneal Dialysis, 2018, 12(38):S16-S18
[3]王兰，汪涛.腹膜透析中心管理模式的建立与体会[J].中华护理杂志, 2004, 39(7):546-547
[4]芦丽霞，赵慧萍.专职腹膜透析护士在腹膜透析患者长期随访中的作用[J].中国血液净化, 2014, 13(2):119-121
[5]汪涛，王兰.加强护士在腹膜透析治疗中的作用[J].中华护理杂志, 2002, 37(12):933-935
[6] William L Salzer.Peritoneal dialysis-related peritonitis: challenges and solutions[J]. [J].Int J Nephrol Renovasc Dis, 2018, (11):173-186
[7]Mehrotra R, Devuyst O, Davies S J, et al.The Current State of Peritoneal Dialysis[J].Journal of the American Society of Nephrology, 2016, 27(11):3238-3252
[8]LiPK，SzetoCC，Piraino B，et al.ISPD Peritonitis Recommendations: 2016 Update on Prevention and Treatment[J].Perit Dial lnt, 2016, 36(5):481-508
[9]中国腹膜透析相关感染防治专家组.腹膜透析相关感染的防治指南[J].中华肾脏病杂志, 2018, 34(2):139-148
[10]Crabtree J H, Shrestha B M, Chow K M, et al.International Society for Peritoneal Dialysis GuidelinesRecommendations Creating and Maintaining Optimal Peritoneal Dialysis Access in the Adult Patient: 2019 Update[J].Peritoneal dialysis international: journal of the International Society for Peritoneal Dialysis, 2019, 39(5):414-436
[11]Szeto C C，Li K T，Johnson D W，et al.ISPD Catheter-Related Infection Recommendations：2017 Update[J].Peritoneal Dialysis International Journal of the International Society for Peritoneal Dialysis, 2017, 37(2):141-154
[12] Aykut S，Caner C，Ozkan G，et al.Mupirocin application at the exit site in peritoneal dialysis patients：five years of experience[J][J].Ren Fail, 2010, 32(3):356-361
[13] Cho Y，Johnson DW.Peritoneal dialysis-related peritonitis：towards improving evidence，practices and outcomes[J][J].Am J Kidney Dis, 2014, 64(2):278-289
[14] Wang J，Zhang H，Liu J，et al.Implementation of a continuous quality improvement program reduces the occurrence of peritonitis in PD[J][J].Ren Fail, 2014, 36(7):1029-1032
[15]Yu Y，Zhou Y，Wang H，et al.Impact of continuous quality improvement initiatives on clinical outcomes in peritoneal dialysis[J].Perit Dial Int, 2014, 34(Suppl 2):S43-48
[16] Schaefer F，Klaus G，Müller-Wiefel DE，et al.Intermittent versus continu- ous intraperitoneal glycopeptide/ceftazidime treatment in children with peritoneal dialysis-associated peritonitis[J][J]. J Am Soc Nephrol, 1999, 10(1):136-145
[17] Brown EA，Blake PG，Boudville N，et al..International Society for Peritoneal Dialysis practice recommendations: Prescribing high-quality goal-directed peritoneal dialysis[J][J].Peritoneal Dialysis International, 2020, 40(3):244-253
[18]赵慧萍，王梅.年国际腹膜透析学会《处方高质量、目标为导向的腹膜透析》指南推荐解读[J].中国血液净化, 2020, 19(12):793-797
[19]Jegatheesan D，Cho Y，Johnson D W.Clinical Studies of Interventions to Mitigate Cardiovascular Risk in Peritoneal Dialysis Patients[J].Seminars in Nephrology, 2018, 38(3):277-290
[20]Hou F，Jiang J, Chen J, et al.China collaborative study on dialysis: a multicenters cohort study on cardiovascular diseases in patients on maintenance dialysis[J].BMC Nephrology, 2012, 13(1):94-94
[21]WangAY，BrimbleKS，BrunierG，et al.ISPD cardiovascular and metabolic guidelines in adult peritoneal dialysis patients Part I- asessment and management of various cardiovascular risk factors[J].Perit Dial Int, 2015, 35(4):379-387
[22]WangAY，BrimbleKS，BrunierG，et al.ISPD cardiovascular and metabolic guidelines in adult peritoneal dialysis patients Part II-management of various cardiovascular complications[J].Perit Dial Int, 2015, 35(4):388-396
[23]李军辉，汪年松.国际腹膜透析协会成年腹膜透析患者心血管及代谢管理指南解读[J].世界临床药物, 2016, 37(8):513-517
[24] Hurst，Helen.A NEW PERITONEAL DIALYSIS TRAINING GUIDELINE FROM THE ISPD NURSING COMMITTEE[J][J].Peritoneal dialysis international: Journal of the International Society for Peritoneal Dialysis, 2016, 36(6):585-586
[25]Qiang Yao，Jie，et al.WHAT PD RESEARCH IN CHINA TELLS US[J].Peritoneal Dialysis International Journal of the International Society for Peritoneal Dialysis, 2018, 38(Suppl 2):S19-S24
